Article

Multiple approaches show benefit in treating orchialgia

In this interview, Jamin Brahmbhatt, MD, gives his take on several studies of orchialgia and chronic prostatitis/chronic pelvic pain syndrome presented at the 2018 AUA annual meeting.

Two alternative therapies for the treatment of men with orchialgia showed positive results in studies presented at the AUA annual meeting in San Francisco. A third study on another pain-related condition in men found that the addition of low-dose tadalafil (Cialis) to levofloxacin (Levaquin) is well tolerated and significantly improved chronic prostatitis/chronic pelvic pain syndrome symptoms.

An AUA press briefing on the studies was moderated by Jamin Brahmbhatt, MD, of Orlando Health in Clermont, FL. The studies examining orchialgia treatment demonstrated improved symptoms with physical therapy in men who have undergone previous medical and surgical interventions and with the use of trigger point dry needling as a component of physical therapy.

“Dry needling, which has already been used for patients with other forms of chronic pain, including interstitial cystitis, is now being used in men with chronic testicular pain or orchialgia. The study found that there were definitely benefits” when dry needling was added to physical therapy, Dr. Brahmbhatt said in a Urology Times video interview.

 

Related Videos
Chad Tang, MD: Considerations for SBRT in metastatic RCC
Interpreting ART toxicity and tolerability for bladder cancer, with Vedang Murthy, MD
Alexander Pastuszak, MD, PhD: Is hormone therapy safe after prostate cancer radiotherapy?
Refining prostate cancer therapy strategy to address RAPTOR findings
Considering patient-reported outcomes in kidney cancer care, with Nicholas Zaorsky, MD, PhD
Soumyajit Roy, MS, MBBS: The effect of prostate cancer patient history in RAPTOR
 Nicholas Zaorsky, MD, MS: Protecting kidney function after local renal cell carcinoma therapy
Nicholas van AS, MD, MBBCH: The case for SBRT as a standard of care for localized prostate cancer
Pierre Blanchard, MD, PhD: What can hydrogel space provide to optimal prostate cancer care?
Related Content
© 2024 MJH Life Sciences

All rights reserved.